NO20022142L - Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon - Google Patents
Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjonInfo
- Publication number
- NO20022142L NO20022142L NO20022142A NO20022142A NO20022142L NO 20022142 L NO20022142 L NO 20022142L NO 20022142 A NO20022142 A NO 20022142A NO 20022142 A NO20022142 A NO 20022142A NO 20022142 L NO20022142 L NO 20022142L
- Authority
- NO
- Norway
- Prior art keywords
- dopamine
- salt
- treatment
- receptor agonists
- dependent hypertension
- Prior art date
Links
- 102000004073 Dopamine D3 Receptors Human genes 0.000 title 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19953254 | 1999-11-04 | ||
| PCT/EP2000/010770 WO2001032263A1 (de) | 1999-11-04 | 2000-10-31 | Verwendung von dopamin-d3-rezeptor-agonisten in der therapie der salzabhängigen hypertonie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20022142L true NO20022142L (no) | 2002-05-03 |
| NO20022142D0 NO20022142D0 (no) | 2002-05-03 |
Family
ID=7928007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022142A NO20022142D0 (no) | 1999-11-04 | 2002-05-03 | Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1233815A1 (no) |
| JP (1) | JP2003513053A (no) |
| KR (1) | KR20020062300A (no) |
| CN (1) | CN1387450A (no) |
| AU (1) | AU1390801A (no) |
| BR (1) | BR0015310A (no) |
| CA (1) | CA2389643A1 (no) |
| CZ (1) | CZ20021521A3 (no) |
| HU (1) | HUP0203024A2 (no) |
| IL (1) | IL149266A0 (no) |
| MX (1) | MXPA02004103A (no) |
| NO (1) | NO20022142D0 (no) |
| RU (1) | RU2002114818A (no) |
| WO (1) | WO2001032263A1 (no) |
| ZA (1) | ZA200204455B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1180599A1 (de) * | 2000-08-16 | 2002-02-20 | Siemens Building Technologies AG | Sicherheitstechnische Einrichtung für eine Pumpe, die in einem Fluidgetriebe verwendet werden kann |
| JP2010184889A (ja) * | 2009-02-12 | 2010-08-26 | Nihon Univ | 高血圧症予防治療薬 |
| JP5738875B2 (ja) * | 2009-10-16 | 2015-06-24 | エピオメド セラピューティクス， インク． | 催吐治療 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5147196A (en) * | 1995-03-27 | 1996-10-16 | Smithkline Beecham Plc | Bicyclic amine derivatives and their use as anti-psychotic a gents |
| FR2742149B1 (fr) * | 1995-12-11 | 1998-02-13 | Inst Nat Sante Rech Med | Nouveaux derives de 2-naphtamides et leurs applications therapeutiques |
-
2000
- 2000-10-31 HU HU0203024A patent/HUP0203024A2/hu unknown
- 2000-10-31 CA CA002389643A patent/CA2389643A1/en not_active Abandoned
- 2000-10-31 JP JP2001534466A patent/JP2003513053A/ja active Pending
- 2000-10-31 RU RU2002114818/15A patent/RU2002114818A/ru not_active Application Discontinuation
- 2000-10-31 CZ CZ20021521A patent/CZ20021521A3/cs unknown
- 2000-10-31 CN CN00815203A patent/CN1387450A/zh active Pending
- 2000-10-31 IL IL14926600A patent/IL149266A0/xx unknown
- 2000-10-31 MX MXPA02004103A patent/MXPA02004103A/es not_active Application Discontinuation
- 2000-10-31 EP EP00975979A patent/EP1233815A1/de not_active Withdrawn
- 2000-10-31 WO PCT/EP2000/010770 patent/WO2001032263A1/de not_active Ceased
- 2000-10-31 AU AU13908/01A patent/AU1390801A/en not_active Abandoned
- 2000-10-31 KR KR1020027005750A patent/KR20020062300A/ko not_active Withdrawn
- 2000-10-31 BR BR0015310-9A patent/BR0015310A/pt not_active Application Discontinuation
-
2002
- 2002-05-03 NO NO20022142A patent/NO20022142D0/no not_active Application Discontinuation
- 2002-06-04 ZA ZA200204455A patent/ZA200204455B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001032263A1 (de) | 2001-05-10 |
| EP1233815A1 (de) | 2002-08-28 |
| CA2389643A1 (en) | 2001-05-10 |
| ZA200204455B (en) | 2003-09-04 |
| CN1387450A (zh) | 2002-12-25 |
| AU1390801A (en) | 2001-05-14 |
| RU2002114818A (ru) | 2004-01-10 |
| NO20022142D0 (no) | 2002-05-03 |
| HUP0203024A2 (hu) | 2003-02-28 |
| KR20020062300A (ko) | 2002-07-25 |
| JP2003513053A (ja) | 2003-04-08 |
| MXPA02004103A (es) | 2003-08-20 |
| BR0015310A (pt) | 2002-07-09 |
| IL149266A0 (en) | 2002-11-10 |
| CZ20021521A3 (cs) | 2003-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022925D0 (no) | EP4 reseptor selektive agonister for behandling av osteoporose | |
| NO20032360D0 (no) | EP4 reseptor selektive agonister for behandling av osteoporose | |
| PT1189916E (pt) | N-pirazole agonistas do receptor a2a | |
| NO20014379L (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| NO20022105D0 (no) | Positive modulatorer av nikotinreseptoragonister | |
| NO20030213D0 (no) | Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi | |
| DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
| NO20034122D0 (no) | Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte | |
| NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| DK1446379T3 (da) | Arylanilin-beta2-adrenergiske receptoragonister | |
| NO20016246L (no) | Selektiv iGluR5 reseptorantagonist for behandling av migrene | |
| NO20020574D0 (no) | Substituerte 1,5-dihydropyrrol-2-onderivater som er virksomme som NMDA-reseptorantagonister for behandlingen av smertetilstanden | |
| DE60028368D1 (de) | Agonisten des peroxisom aktivator-responsiven rezeptors | |
| NO20013997L (no) | Reseptoranalyse | |
| NO20032304L (no) | Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon | |
| ID30056A (id) | Agonis-agonis 5-htif | |
| NO20022142D0 (no) | Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon | |
| NO20021295L (no) | Nikotinsyreacetylcholin-reseptor | |
| DE60023020T2 (de) | Positive modulatoren von nicotinrezeptor-agonisten | |
| ID30381A (id) | Penggunaan arilalkanoilpiridazina | |
| NO20014904D0 (no) | Fremgangsmåte for forspenning av en ankerline | |
| SE9904449D0 (sv) | Activtor of the vanilloid receptor | |
| TR199901524A3 (tr) | Endojen evrede melatoninin serbest kalmasi. | |
| DK1200402T3 (da) | Substituerede 1,5-dihydropyrrol-2-on-derivater med virkning som NMDA-receptorantagonister til behandling af smertetilstande |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |